Literature DB >> 15773140

[Corticosteroid therapy].

W H Reinhart1.   

Abstract

Synthetic corticosteroids have variable glucocorticoid and mineralocorticoid potencies. Depending on their galenic form they can be administered either by intravenous, oral, intraarticular, intramuscular, inhalative or topic route. A local application is preferable over a systemic administration to avoid side effects. An initially high dose should always be tapered to the lowest possible effective dose. Among the side effects some have substantial clinical implications: Osteoporosis (to be treated during any long-term steroid application with calcium, vitamin D and eventually bis-phosphonates), immunodeficiency and a risk for often atypical infections, diabetes mellitus and psychiatric disorders such a depression and psychosis. A long-term glucocorticoid treatment can lead to a permanent adrenal insufficiency (M. Addison), which must be recognized and properly managed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773140     DOI: 10.1024/0369-8394.94.7.239

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  5 in total

1.  And Tell Yourself, "This is not Me, it's the Drug": Coping with the Psychological Impact of Corticosteroid Treatments in Hematology - Further Results from a Pilot Study.

Authors:  Pam McGrath; Mary Anne Patton; Michael Leahy
Journal:  Patient       Date:  2009-03-01       Impact factor: 3.883

2.  "I was never like that": Australian findings on the psychological and psychiatric sequelae of corticosteroids in haematology treatments.

Authors:  Pam McGrath; Mary Anne Patton; Sarah James
Journal:  Support Care Cancer       Date:  2008-05-14       Impact factor: 3.603

3.  A Fatal Sepsis Caused by Hyaluronate Knee Injection: How Much the Medical History and the Informed Consent Might Be Important?

Authors:  F Manfreda; G Rinonapoli; A Nardi; P Antinolfi; A Caraffa
Journal:  Case Rep Orthop       Date:  2017-02-23

4.  Saireito (114) Increases IC50 and Changes T-Cell Phenotype When Used in Combination with Prednisolone Therapy in Human Peripheral Blood Mononuclear Cells.

Authors:  Kyosuke Yamazaki; Anna Kiyomi; Shinobu Imai; Munetoshi Sugiura
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-28       Impact factor: 2.629

5.  Systemic glucocorticoid prescriptions pattern and factors of inappropriate use in primary care institutions of Southwest China.

Authors:  Xiaobo Luo; Shitao Yu; Zhen Zeng; Xunrong Zhou; Yuxi Liu; Lei Wang; Jiaqi Hu; Yue Chang
Journal:  Front Public Health       Date:  2022-09-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.